SPONSOR
The University of Queensland
Total Trials
4
Recruiting
4
Phases
Phase 2, Phase 3, Phase 2, Phase 3
Conditions studied: Parkinson DiseaseMild Cognitive ImpairmentMemory ImpairmentBK ViremiaKidney Transplant InfectionKidney Transplant Failure and RejectionPulmonary Disease Due to Mycobacteria (Diagnosis)Kidney Failure
The University of Queensland is a clinical research sponsor with 4 registered studies on ClinicalTrials.gov, of which 4 are actively recruiting participants. Research covers conditions including Parkinson Disease, Mild Cognitive Impairment, Memory Impairment, BK Viremia.
The trial portfolio spans Phase 2, Phase 3, Phase 2, Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — The University of Queensland
How many clinical trials has The University of Queensland sponsored?
ClinicalMetric currently tracks 4 clinical trials sponsored by The University of Queensland, of which 4 are actively recruiting participants. These trials cover conditions including Parkinson Disease, Mild Cognitive Impairment, Memory Impairment. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does The University of Queensland research focus on?
The University of Queensland clinical trials span Parkinson Disease, Mild Cognitive Impairment, Memory Impairment, BK Viremia, Kidney Transplant Infection, and additional conditions. The research pipeline includes Phase 2, Phase 3, Phase 2, Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a The University of Queensland clinical trial?
To participate in a The University of Queensland trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all The University of Queensland trials with current recruitment status updated daily.
Clinical Trials by The University of Queensland
NCT04643327 Phase 2
Recruiting
Uncovering a Novel Therapeutic Target to Reduce Dementia Risk in Parkinson's Disease
Parkinson Disease
NCT05325008 Phase 3
Recruiting
A Trial to Treat Polyomavirus Infections (BKPyV) in Kidney and Simultaneous Kidney Pancreas Transplant Recipients
BK Viremia
NCT04310930 Phase 2, Phase 3
Recruiting
Finding the Optimal Regimen for Mycobacterium Abscessus Treatment
Pulmonary Disease Due to Mycobacteria (Diagnosis)
NCT04932148
Recruiting
INCremental Dialysis to Improve Health Outcomes in People Starting Haemodialysis (INCH-HD)
Kidney Failure
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology